The Journal of Clinical and Aesthetic Dermatology

James Del Rosso, DO: New and Exciting Indications for Bimekizumab, Nemolizumab, and Lebrikizumab

1.0x

0% played 00:00 00:00

Other Episodes

Dr. Del Rosso discusses three exciting new indications for drugs in dermatology and how these approvals will impact clinical practice.

Download episode Share

Copy URL